FREQUENCY OF P53 EXPRESSION IN EPITHELIAL OVARIAN CANCER

  • Aafia Qasim Chughtai Institute of Pathology
  • Omer Rasheed Chughtai Chughtai Institute of Pathology
  • Muhammad Fayyaz Anwar PGMI/LGH/AMC
  • Asma Zafar Chughtai Institute of Pathology
  • AS Chughtai Chughtai Institute of Pathology, Lahore
  • Samina Zaman Chughtai Institute of Pathology, Lahore
Keywords: Ovary,p 53,Cancer,Immunochemistry

Abstract

Background: The ovarian carcinomas are the most cause of death in women due to cancer. The most common and lethal gynecological malignancy is malignant epithelial tumor.p53 may be used as a marker to predict aggressive behavior and poor response to standard chemotherapy.

Objective: To observe the frequency of positive immunohistochemical expression of p53 in surface epithelial carcinoma.

Materials and methods: A cross-sectional study for immunohistochemical expression of p53 on 100 diagnosed cases of surface epithelial carcinoma was conducted in the department of Histopathology, Chughtai Institute of of Pathology, Lahore during a period of 6 months. Nuclear staining for p53 was considered as positive. Cases with more than 10% positivity in tumor cells were considered as positive.

Results: The mean age of patients and size of tumor were 48.70 ± 10.5 1 years and 9.83 ± 5.33 cm respectively. 25% (n=25) patients had low histologic grades while 75%(n=75) patients had high histological grades.47% (n=47)patients were p53 positive and 53% (n=53) patients were negative for immunohistochemical expression of p53.

Conclusion: The present study states p53 positivity in 47% cases of epithelial ovarian cancer and the data fits to the proposed dualistic pathway of ovarian carcinogenesis as expression of p53 positive cases in high grade cancers is statistically significant ( <0.05).

Author Biographies

Aafia Qasim, Chughtai Institute of Pathology

Consultant Histopathologist

Omer Rasheed Chughtai, Chughtai Institute of Pathology

Consultant Histopathologist

AS Chughtai, Chughtai Institute of Pathology, Lahore

Professor of Histopathology

Published
2022-10-22